NTI164: Clinical Trials

3 trials of NTI164, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 not yet recruiting, 1 completed. 3 Phase 3, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 33Not yet recruiting 2, Completed 1
Phase 22Completed 1, Not yet recruiting 1

Follow NTI164: new trials by email Literature Review of NTI164 trials Research Report on NTI164

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Efficacy and Safety of NTI164 in Children and Young Adults With Rett Syndrome
NTI164, Placebo - RETT Syndrome With Proven MECP2 Mutation, Rett Syndrome
Phase 2 / Phase 3Not yet recruitingFenix Innovation Group402027-07-012026-09-09
NTI164 in Autism Spectrum Disorder
NTI164, Placebo - Autism, Autism Spectrum Disorder
Phase 3Not yet recruitingFenix Innovation Group2002026-09-302026-09-30
Evaluating the Efficacy of NTI164 in Young People With Autism Spectrum Disorder
NTI164 - Autism Spectrum Disorder
Phase 2 / Phase 3CompletedFenix Innovation Group542022-11-302026-09-10

Conditions studied

Autism Spectrum Disorder (2)  ·  Marijuana Abuse (2)  ·  Autistic Disorder (1)  ·  Rett Syndrome (1)

Sponsors

Fenix Innovation Group (3)

Countries

Australia (3)

Top investigators

Michael Fahey, Prof (1)